Bioorganic & Medicinal Chemistry Letters · 2013 · 24 citations · 20 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DesignDrug DiscoveryChemical Library DesignChemical Space ExplorationDrug-receptor InteractionsDrug-target Interaction MappingLigand BindingProtein-ligand DockingAffinity ScreeningDrug-target Interaction AnalysisLigand-based ScreeningTarget-ligand Interactions
20
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.7K citations
Medicine, Oncology, Pharmacology +15
Mdm2 promotes the rapid degradation of p53
Ygal Haupt, Ruth Maya, Anat Kazaz et al. · Nature · 1997 · 4.5K citations
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Reiko Honda, Hirofumi Tanaka, Hideyo Yasuda · FEBS Letters · 1997 · 1.9K citations
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Jonathan D. Oliner, Jennifer A. Pietenpol, Sam Thiagalingam et al. · Nature · 1993 · 1.5K citations
Medicine, Cancer Biology, Oncology +16